Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

Also called NCT06597201

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Chengdu Qingshan Likang Pharmaceutical Co., Ltd (from the registry)
Registry
  • NCT NCT06597201
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06597201. Randomized; no masking; primary purpose treatment. Start 2024-08-09 (actual); primary completion 2025-06-29 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
Condition
End Stage Renal Disease (ESRD)
Intervention (Drug)
amino acid (15) peritoneal dialysis solution
Intervention (Drug)
glucose peritoneal dialysis solution
Lead sponsor
Chengdu Qingshan Likang Pharmaceutical Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct06597201
Content hash
83e8004ae2f79b415f8cdc82c0004d6324b55fc09c96982e43f12051b1c5e6df